AVITA Medical Lands 10-Year BARDA Agreement Worth Up to $25.5M for Burn Preparedness
summarizeSummary
AVITA Medical has secured a 10-year agreement with the Biomedical Advanced Research and Development Authority (BARDA), valued at up to $25.5 million, to enhance U.S. burn emergency preparedness. The agreement guarantees approximately $3.97 million in annual access-maintenance fees and readiness support over the decade, with the remaining value contingent on BARDA's procurement options. This partnership provides a new, long-term revenue stream and validates AVITA Medical's RECELL product, which is particularly significant given the company's recent 'going concern' warning in its 2025 annual report. While the guaranteed annual revenue is modest, the potential for additional procurement up to $25.5 million over 10 years is a material positive for a company with a market capitalization of approximately $125 million. Investors will be watching for updates on actual procurement orders and the overall impact on the company's financial stability.
At the time of this announcement, RCEL was trading at $4.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $125.6M. The 52-week trading range was $3.22 to $10.29. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.